首页 工具
登录
购物车

搜索结果

Search Results for " antiproliferation "

11

抑制剂 & 化合物

2

天然产物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T6712 Tyrphostin AG 879

AG 879

Apoptosis; EGFR; Trk receptor; HER; PDGFR Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
Tyrphostin AG 879 (AG 879) 是一种抑制TrKA 磷酸化的酪氨酸激酶抑制剂,IC50为 10 μM。它还是一种选择性ErbB2酪氨酸激酶抑制剂,IC50为 1 μM,具有抗癌活性。
T9003 CVT-11127

N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺

Dehydrogenase Metabolism
CVT-11127 是 SCD 抑制剂。它将细胞周期阻滞在 G1/S 期,诱导细胞凋亡。它可用于肺癌的研究。
T64387 2-Nitrobenzoic acid

o-Nitrobenzoic acid

Others Others
2-Nitrobenzoic acid (o-Nitrobenzoic acid) 是一种抗增殖化合物,对表达 T 型钙通道α1H 或其剪接变体δ25的 jurkat 细胞系显示出8.3μM 的 IC50。
T27524 H8-A5

H8 A5

H8-A5, a HDAC8 inhibitor, shows antiproliferation activity in MDA-MB-231 cancer cells.
T26238 Sumarotene

Ro14-9706,Ro-14-9706,Ro 14-9706

Sumarotene, a third-generation retinoid, is used as a topical dermatologic agent for the repair of antikeratinization, photodamage, and antiproliferation.
T61429 HDAC-IN-33

HDAC-IN-33 is a highly potent HDAC inhibitor, effectively inhibiting HDAC1, HDAC2, and HDAC6 with IC50 values of 24, 46, and 47 nM, respectively. This compound demonstrates significant antiproliferation activity against tumor cells and exhibits remarkable in vivo antitumor efficacy. Additionally, HDAC-IN-33 initiates the activation of antitumor immunity [1].
T70628 Cmpd-A

Cmpd-A is a time-dependent CENP-E inhibitor with potent antitumor activity. Cmpd-A inhibits the ATPase activity of the CENP-E motor domain, acting as a time-dependent inhibitor with an ATP-competitive-like behavior. Cmpd-A causes chromosome misalignment on the metaphase plate, leading to prolonged mitotic arrest. Treatment with Cmpd-A induces antiproliferation in multiple cancer cell lines.
T71267 GNF-8625

GNE-8525 is a potent and selective pan-TRK inhibitor. GNE-8525 demonstrated potent antiproliferation activity with IC50 = 0.003 μM. In a tumor xenograft model derived from the KM12 cell line, GNE-8525 demonstrated in vivo antitumor efficacy when administered at ascending doses twice daily (bid) for 14 days in rats. Deregulated kinase activities of tropomyosin receptor kinase (TRK) family members have been shown to be associated with tumorigenesis and poor prognosis in a variety of cancer type...
T61978 ACC1/2-IN-2

ACC1/2-IN-2 (compound PF-3) 是有效的 ACC1/2抑制剂,IC50分别为 22 和 48 nM。 ACC1/2-IN-2 显示出抗增殖活性,可用于癌症相关研究。
T63351 MS8511

MS8511 是一种选择性的G9a/GLP 共价的不可逆抑制剂,可靶向底物结合位点的半胱氨酸残基,IC50值为 100 nM ( G9a) 和 140 nM (GLP),Kd 值44 nM (G9a) 和 46 nM (GLP)。 MS8511 可降低细胞内 H3K9me2 水平并提高抗增殖活性。MS8511 可用于研究多种癌症 (包括脑癌、乳腺癌、卵巢癌、肺癌、膀胱癌、黑色素瘤、结肠直肠癌) 和其他疾病,如阿尔茨海默病 (AD)、镰状细胞病、Prader-Willi 综合征 (PWS).
T36628 PROTAC BRD4 Degrader-8

PROTAC BRD4 Degrader-8

PROTAC BRD4 Degrader-8 is a potent BRD4 inhibitor, with IC50s of 1.1 nM and 1.4 nM for BRD4 BD1 and BD2, respectively. PROTAC BRD4 Degrader-8 is capable of potently degrading the BRD4 protein in PC3 prostate cancer cells[1]. PROTAC BRD4 Degrader-8 (compound 8; 6 days) inhibits the proliferation of PC3 prostate cancer cells, with an IC50 of 28 nM[1].PROTAC BRD4 Degrader-8 (4 h) suppresses MYC gene transcript in MV4-11 AML cells, with an IC50 of 11 nM[1].PROTAC BRD4 Degrader-8 (4 h) potently degra...

化合物

Tyrphostin AG 879
Cat.No: T6712
Synonym: AG 879
Target: Apoptosis, EGFR, Trk receptor, HER, PDGFR
CVT-11127
Cat.No: T9003
Synonym: N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺
Target: Dehydrogenase
2-Nitrobenzoic acid
Cat.No: T64387
Synonym: o-Nitrobenzoic acid
Target: Others
H8-A5
Cat.No: T27524
Synonym: H8 A5
Target:
Sumarotene
Cat.No: T26238
Synonym: Ro14-9706,Ro-14-9706,Ro 14-9706
Target:
HDAC-IN-33
Cat.No: T61429
Synonym:
Target:
Cmpd-A
Cat.No: T70628
Synonym:
Target:
GNF-8625
Cat.No: T71267
Synonym:
Target:
ACC1/2-IN-2
Cat.No: T61978
Synonym:
Target:
MS8511
Cat.No: T63351
Synonym:
Target:
PROTAC BRD4 Degrader-8
Cat.No: T36628
Synonym: PROTAC BRD4 Degrader-8
Target:
Cat. No. Product Name Target Signaling Pathways
T2P2806 Hederacolchiside A1

黑海常春藤苷A1,革叶常春藤皂苷 A1,Raddeanoside R13

Apoptosis; ERK; MEK; Akt; PI3K; Parasite; mTOR Apoptosis; Cytoskeletal Signaling; MAPK; Microbiology/Virology; PI3K/Akt/mTOR signaling
Hederacolchiside A1 (Raddeanoside R13) 是从白头翁中分离的一种有抗利什曼原虫和抗肿瘤增殖活性的天然产物。
T36715 Tetrac

Tetraiodothyroacetic acid,3,3',5,5'-Tetraiodothyroacetic acid

Apoptosis; EGFR Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
Tetrac (Tetraiodothyroacetic acid)是L-甲状腺素(T4)的衍生物,是一种甲状腺整合素受体拮抗剂。Tetrac通过阻断EGFR介导的结直肠癌细胞信号传导来诱导抗增殖。Tetrac 可阻断 T4 和 3,5,3'-triiodo-L-thyronine (T3)在细胞表面甲状腺素整合素 αvβ3 受体上的作用。Tetra 具有抗血管生成、抗肿瘤活性和促凋亡活性。

天然产物

Hederacolchiside A1
Cat.No: T2P2806
Synonym: 黑海常春藤苷A1,革叶常春藤皂苷 A1,Raddeanoside R13
Target: Apoptosis, ERK, MEK, Akt, PI3K, Parasite, mTOR
Tetrac
Cat.No: T36715
Synonym: Tetraiodothyroacetic acid,3,3',5,5'-Tetraiodothyroacetic acid
Target: Apoptosis, EGFR
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼